There are many ongoing advances in the context of radiation therapy delivery for patients with primary soft tissue sarcoma of the extremity/trunk with emerging practice-changing clinical research and new treatment options, some of which are not yet standard of care.

This presentation will review unique challenges in the diagnosis and management of angiosarcoma as well as advances in targeted therapy and immunotherapy for angiosarcoma.

The purpose of this presentation is to review characteristic multimodality imaging features of soft tissue sarcoma (STS), discuss MRI imaging protocols, identify imaging features of STS that may allow for a specific diagnosis or narrow the differential diagnosis, cover potential imaging pitfalls,

Sarcomas are a rare and heterogenous group of malignancies requiring a multidisciplinary approach for optimal management.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a business fundamentals review and a radiopharmaceuticals overview.

There is a general understanding and comfort in management of small, relatively well-defined SCC of the skin, even those that carry some high risk features (PNI, high DOI, high grade, etc).